Intended for healthcare professionals

Latest dermatology news

 

Boehringer receives NICE recommendation for Spevigo in generalised pustular psoriasis

The decision gives patients access to a therapy that targets the interleukin-36 pathway for the first time

26 Jun 2025

UCB shares three-year results for Bimzelx in psoriatic arthritis

Psoriatic arthritis affects around 30% of psoriasis patients

26 Jun 2025

Sanofi/Regeneron share phase 4 results for Dupixent in atopic dermatitis

The trial has been evaluating the drug in patients with darker skin tones

19 Jun 2025

Galderma’s Nemluvio shows sustained improvements in atopic dermatitis

The long-term study has been evaluating the drug in over 1,900 patients with moderate-to-severe cases

12 Jun 2025

Dermaliq and DEBRA enter epidermolysis bullosa partnership

The partners will aim to advance cutaneous drug delivery for the rare genetic skin disorders

05 Jun 2025

FDA grants interchangeable designation to Celltrion’s Yuflyma

The drug is approved for plaque psoriasis, hidradenitis suppurativa and other inflammatory conditions

29 May 2025

GSK’s linerixibat shows promise in PBC-related itch

Up to 90% of patients primary biliary cholangitis experience pruritus

21 May 2025

FDA approves Abeona’s Zevaskyn to treat epidermolysis bullosa

The gene therapy demonstrated significant wound healing and pain reduction in RDEB

15 May 2025

Sanofi/Regeneron announce FDA approval for Dupixent in urticaria

Over 300,000 chronic spontaneous urticaria patients in the US are inadequately controlled by antihistamines

09 May 2025

LEO and the Parker Institute enter three-year dermatology partnership

The agreement will focus on enhancing skin disease understanding

01 May 2025
12345678910...